<ul>
<li>Quest Laboratories made a strong debut on Thursday, May 23, listing at a premium of nearly 60% at ₹155 apiece against its issue price of ₹97 on NSE.</li>
<li>The IPO, with a size of ₹43.16 crore, opened for subscription on Wednesday, May 15, and concluded on Friday, May 17.</li>
<li>"Quest Laboratories shares rose further to hit the level of ₹159 but eased later and traded at ₹147.35 around 10:35 am," reported a market analyst.</li>
</ul>
<p><strong>Quest Laboratories IPO sees robust demand, lists at 60% premium on NSE.</strong></p>
<h2><strong>Quest Laboratories' Impressive Market Debut</strong></h2>
<p>Quest Laboratories' shares made a remarkable debut on the NSE, listing at ₹155 per share, a 60% premium over its issue price of ₹97. This strong opening reflects the high investor confidence and robust demand for the company's shares. The stock further surged to ₹159 before stabilizing at ₹147.35 by 10:35 am.</p>
<h3><strong>IPO Subscription and Allotment Details</strong></h3>
<p>The ₹43.16 crore IPO of Quest Laboratories was open for subscription from May 15 to May 17, with the price band set at ₹93 to ₹97 per share. The IPO saw overwhelming interest, being subscribed 85.26 times overall. The retail category was subscribed 57.63 times, the qualified institutional buyers (QIB) category 57.20 times, and the non-institutional investors (NII) category a staggering 184.10 times.</p>
<h2><strong>Utilization of IPO Proceeds</strong></h2>
<p>Quest Laboratories plans to use the net proceeds from the IPO to fund capital expenditures, including the purchase of plant and machinery for expansion at its existing manufacturing facility, working capital requirements, and general corporate purposes. This strategic allocation of funds is expected to bolster the company's operational capabilities and support its growth trajectory.</p>
<h3><strong>Company Overview and Market Presence</strong></h3>
<p>Quest Laboratories is a pharmaceutical company operating in the domestic market across twelve states and two union territories. Its manufacturing unit is located in Dhar, Madhya Pradesh. The company's strong market presence and strategic location of its manufacturing facility are key factors contributing to its competitive edge in the industry.</p>
<h3><strong>Market Reaction and Broader Stock Market Performance</strong></h3>
<p>On the day of Quest Laboratories' listing, the Indian stock market benchmarks, the Sensex and the Nifty 50, also traded with decent gains. The Sensex opened at 74,253.53 and rose over half a percent to an intraday high of 74,632.36. Similarly, the Nifty 50 opened at 22,614.10 and climbed to 22,719.35 by 10:30 am. This positive market sentiment further underscores the favorable conditions for new listings.</p>
<h3><strong>Conclusion</strong></h3>
<p>Quest Laboratories' successful IPO and strong market debut highlight the company's solid fundamentals and growth potential. The overwhelming subscription rates across various investor categories reflect high confidence in the company's future prospects. As Quest Laboratories continues to expand and enhance its operational capabilities, it is well-positioned to capitalize on emerging opportunities in the pharmaceutical sector.</p>
Disclaimer: The contents on Coinotag.com require technical knowledge. Coinotag.com cannot be held liable for any gains or losses and investments are subject to risks. It is important to conduct your own research. The advertisements on Coinotag.com are carried out through third-party advertising channels. Therefore, the ad links referred from Coinotag.com are independent of Coinotag.com's approval and the visits directed through these ad links are the responsibility of the user.